Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.
T J VoglM C LangenbachR HammerstinglM H AlbrechtA R ChatterjeeTatjana Gruber-RouhPublished in: Hepatology international (2021)
The additional application of DSM during cTACE showed a significant benefit in tumor response according to mRECIST compared to cTACE with Lipiodol-only. No benefit in survival time was observed.